Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 04-Oct-18 6:48 AM View:  | Trieu Vuong Director 10% Owner | Adhera Therapeutics, Inc. (ATRX) | 01-Oct-18 | Disposition | 500,000 | $0.50 | $250,000.00 | (12%) 4.04M to 3.54M | |
| 12-Jun-17 5:00 PM View: | Trieu Vuong Chairman of the Board Director 10% Owner | Adhera Therapeutics, Inc. (ATRX) | 09-Jun-17 | Market Purchase | 10,000 | $0.39 | $3,900.00 | < 1% 42.29M to 42.3M | 0% |
| 08-Jun-17 6:30 PM View: | Trieu Vuong Chairman of the Board Director 10% Owner | Adhera Therapeutics, Inc. (ATRX) | 08-Jun-17 | Purchase | 20,000 | $0.39 | $7,800.00 | < 1% 42.27M to 42.29M | |
| 08-Jun-17 6:30 PM View: | Trieu Vuong Chairman of the Board Director 10% Owner | Adhera Therapeutics, Inc. (ATRX) | 07-Jun-17 | Purchase | 2,500 | $0.38 | $950.00 | < 1% 42.26M to 42.27M | |
| 07-Apr-17 12:50 PM View: | Ramelli Joseph W. Chief Executive Officer | Adhera Therapeutics, Inc. (ATRX) | 07-Apr-17 | Market Purchase | 22,500 | $0.43 | $9,562.50 | 5% 418.15K to 440.65K | (6%) |
| 07-Apr-17 12:50 PM View: | Ramelli Joseph W. Chief Executive Officer | Adhera Therapeutics, Inc. (ATRX) | 06-Apr-17 | Market Purchase | 13,000 | $0.34 | $4,368.00 | 3% 405.15K to 418.15K | 20% |
| 05-Apr-17 5:41 PM View: | Ramelli Joseph W. Chief Executive Officer | Adhera Therapeutics, Inc. (ATRX) | 05-Apr-17 | Market Purchase | 97,550 | $0.31 | $30,435.60 | 32% 307.6K to 405.15K | 29% |
| 08-Feb-17 5:30 PM View: | Trieu Vuong Chairman of the Board Director 10% Owner | Adhera Therapeutics, Inc. (ATRX) | 06-Feb-17 | Purchase | 862,068 | $0.29 | $250,000.00 | 2% 39.47M to 40.34M | |
| 03-Feb-17 12:46 PM View: | Ramelli Joseph W. Chief Executive Officer | Adhera Therapeutics, Inc. (ATRX) | 02-Feb-17 | Grant | 100,000 | -- | -- | 48% 207.6K to 307.6K | |
| 22-Nov-16 4:02 PM View: | Trieu Vuong Chairman of the Board Director 10% Owner | Adhera Therapeutics, Inc. (ATRX) | 15-Nov-16 | Grant | 28,378,900 | -- | -- | 256% 11.09M to 39.47M | |
| 02-Jan-15 10:40 AM View: | French J Michael President and CEO Director | Adhera Therapeutics, Inc. (ATRX) | 30-Dec-14 | Payment of Exercise | 309,055 | $0.33 | $101,988.00 | (27%) 1.13M to 822.28K | |
| 18-Apr-14 2:20 PM View: | Ramelli Joseph W. Director | Adhera Therapeutics, Inc. (ATRX) | 16-Apr-14 | Market Purchase | 26,300 | $0.76 | $19,998.50 | 15% 181.3K to 207.6K | (41%) |
| 10-Feb-14 8:12 PM View: | Pryor Cashman Llp 10% Owner | Adhera Therapeutics, Inc. (ATRX) | 10-Feb-14 | Market Sale | 15,000 | $1.02 | $15,270.00 | (< 1%) 1.61M to 1.59M | 56% |
| 10-Feb-14 8:12 PM View: | Pryor Cashman Llp 10% Owner | Adhera Therapeutics, Inc. (ATRX) | 07-Feb-14 | Market Sale | 59,000 | $1.01 | $59,413.00 | (4%) 1.67M to 1.61M | 55% |
| 10-Feb-14 8:12 PM View: | Pryor Cashman Llp 10% Owner | Adhera Therapeutics, Inc. (ATRX) | 06-Feb-14 | Market Sale | 34,041 | $0.95 | $32,304.90 | (2%) 1.7M to 1.67M | 53% |
| 06-Jan-14 9:37 AM View: | Ranker Philip C Former Interim CFO & Secretary Director | Adhera Therapeutics, Inc. (ATRX) | 01-Jan-14 | Grant | 897,303 | -- | -- | 358921% 0.25K to 897.55K | |
| 06-Jan-14 9:36 AM View: | French J Michael President and CEO Director | Adhera Therapeutics, Inc. (ATRX) | 01-Jan-14 | Grant | 1,131,000 | -- | -- | 84529% 1.34K to 1.13M | |
| 06-Jan-14 9:38 AM View: | Loren Stefan Director | Adhera Therapeutics, Inc. (ATRX) | 01-Jan-14 | Grant | 181,303 | -- | -- | 100% 0 to 181.3K | |
| 06-Jan-14 9:38 AM View: | Ho Richard Theodore Executive Vice President - R&D | Adhera Therapeutics, Inc. (ATRX) | 01-Jan-14 | Grant | 390,000 | -- | -- | 100% 0 to 390.0K | |
| 06-Jan-14 9:39 AM View: | Ramelli Joseph W. Director | Adhera Therapeutics, Inc. (ATRX) | 01-Jan-14 | Grant | 181,303 | -- | -- | 100% 0 to 181.3K | |
| 04-Oct-13 6:02 PM View: | Pryor Cashman Llp 10% Owner | Adhera Therapeutics, Inc. (ATRX) | 04-Oct-13 | Market Sale | 35,000 | $0.24 | $8,333.50 | (2%) 1.74M to 1.7M | (86%) |
| 04-Oct-13 6:02 PM View: | Pryor Cashman Llp 10% Owner | Adhera Therapeutics, Inc. (ATRX) | 03-Oct-13 | Market Sale | 65,000 | $0.25 | $16,334.50 | (4%) 1.8M to 1.74M | (76%) |
| 17-Aug-11 4:29 PM View: | Parker Peter Director | Adhera Therapeutics, Inc. (ATRX) | 16-Aug-11 | Disposition (other) | 40,200 | $0.24 | $9,603.78 | (32%) 124.21K to 84.01K | 80% |
| 29-Aug-11 4:44 PM View: | French J Michael President and CEO Director | Adhera Therapeutics, Inc. (ATRX) | 31-Mar-11 | Acquisition (other) | 5,000 | $0.60 | $3,000.00 | 148% 3.38K to 8.38K | |
| 29-Aug-11 4:46 PM View: | Garcia Peter S Chief Financial Officer | Adhera Therapeutics, Inc. (ATRX) | 31-Mar-11 | Acquisition (other) | 5,000 | $0.60 | $3,000.00 | 100% 0 to 5.0K | |
| 15-Feb-11 11:47 AM View: | Parker Peter Director | Adhera Therapeutics, Inc. (ATRX) | 11-Feb-11 | Acquisition (other) | 116,253 | -- | -- | 1461% 7.96K to 124.21K | |
| 27-Jan-11 4:08 PM View: | Novartis Bioventures Ltd 10% Owner | Adhera Therapeutics, Inc. (ATRX) | 26-Jan-11 | Market Sale | 74,500 | $1.17 | $87,130.30 | (3%) 2.57M to 2.5M | 96% |
| 27-Jan-11 4:08 PM View: | Novartis Bioventures Ltd 10% Owner | Adhera Therapeutics, Inc. (ATRX) | 25-Jan-11 | Market Sale | 93,005 | $1.12 | $104,567.00 | (3%) 2.66M to 2.57M | 96% |
| 25-Jan-11 4:30 PM View: | Novartis Bioventures Ltd 10% Owner | Adhera Therapeutics, Inc. (ATRX) | 24-Jan-11 | Market Sale | 72,800 | $1.20 | $87,221.60 | (3%) 2.74M to 2.66M | 96% |
| 25-Jan-11 4:30 PM View: | Novartis Bioventures Ltd 10% Owner | Adhera Therapeutics, Inc. (ATRX) | 21-Jan-11 | Market Sale | 69,500 | $1.25 | $87,218.40 | (2%) 2.8M to 2.74M | 97% |
| 21-Jan-11 4:42 PM View: | Novartis Bioventures Ltd 10% Owner | Adhera Therapeutics, Inc. (ATRX) | 20-Jan-11 | Market Sale | 45,700 | $1.35 | $61,697.50 | (2%) 2.86M to 2.81M | 97% |
| 21-Jan-11 4:43 PM View: | Novartis Bioventures Ltd 10% Owner | Adhera Therapeutics, Inc. (ATRX) | 20-Jan-11 | Market Sale | 5,700 | $1.47 | $8,364.00 | (< 1%) 2.81M to 2.8M | 97% |
| 21-Jan-11 4:42 PM View: | Novartis Bioventures Ltd 10% Owner | Adhera Therapeutics, Inc. (ATRX) | 19-Jan-11 | Market Sale | 42,800 | $1.53 | $65,419.00 | (1%) 2.9M to 2.86M | 97% |
| 29-Aug-11 4:44 PM View: | French J Michael President and CEO Director | Adhera Therapeutics, Inc. (ATRX) | 30-Sep-09 | Acquisition (other) | 875 | $4.76 | $4,165.00 | 35% 2.5K to 3.38K | |
| 20-Mar-09 5:41 PM View: | Quay Steven C Director | Adhera Therapeutics, Inc. (ATRX) | 20-Mar-09 | Grant | 731,275 | -- | -- | 168% 435.39K to 1.17M | |
| 11-Aug-08 5:16 PM View: | French J Michael CEO | Adhera Therapeutics, Inc. (ATRX) | 11-Aug-08 | Market Purchase | 10,000 | $0.75 | $7,546.33 | 100% 0 to 10.0K | (99%) |
| 05-Aug-08 5:55 PM View: | Costantino Henry R CSO - Delivery | Adhera Therapeutics, Inc. (ATRX) | 02-Aug-08 | Payment of Exercise | 438 | $1.11 | $486.18 | (2%) 24.48K to 24.05K | 99% |
| 16-Jul-08 8:18 PM View: | Costantino Henry R CSO - Delivery | Adhera Therapeutics, Inc. (ATRX) | 14-Jul-08 | Market Sale | 231 | $1.01 | $233.31 | (< 1%) 24.72K to 24.48K | 99% |
| 03-Jul-08 1:49 PM View: | Costantino Henry R CSO - Delivery | Adhera Therapeutics, Inc. (ATRX) | 02-Jul-08 | Market Sale | 240 | $1.17 | $280.80 | (< 1%) 24.96K to 24.72K | 99% |
| 03-Jul-08 1:49 PM View: | Costantino Henry R CSO - Delivery | Adhera Therapeutics, Inc. (ATRX) | 01-Jul-08 | Market Sale | 81 | $1.19 | $96.39 | (< 1%) 25.04K to 24.96K | 99% |
| 02-Jul-08 4:56 PM View: | Duffy Timothy M Chief Business Officer | Adhera Therapeutics, Inc. (ATRX) | 01-Jul-08 | Market Sale | 200 | $1.19 | $238.00 | (< 1%) 56.59K to 56.4K | 99% |
| 14-May-08 6:55 PM View: | Cross Alexander D Director | Adhera Therapeutics, Inc. (ATRX) | 14-May-08 | Grant | 10,000 | $1.26 | $12,635.00 | 36% 28.0K to 38.0K | (99%) |
| 13-May-08 6:13 PM View: | Thaw Bruce R/fa Director | Adhera Therapeutics, Inc. (ATRX) | 13-May-08 | Market Purchase | 50,000 | $1.17 | $58,521.40 | 44% 114.04K to 164.04K | (99%) |
| 12-May-08 5:27 PM View: | Stanewick Gerald T Director | Adhera Therapeutics, Inc. (ATRX) | 12-May-08 | Market Purchase | 10,000 | $1.14 | $11,400.00 | 6% 165.41K to 175.41K | (99%) |
| 02-Apr-08 4:52 PM View: | Quay Steven C Chairman and CEO Director | Adhera Therapeutics, Inc. (ATRX) | 01-Apr-08 | Acquisition (other) | 3,500 | $2.00 | $6,991.25 | < 1% 431.12K to 434.62K | 24% |
| 02-Apr-08 4:51 PM View: | Brandt Gordon President | Adhera Therapeutics, Inc. (ATRX) | 01-Apr-08 | Acquisition (other) | 1,201 | $2.00 | $2,399.00 | 3% 40.5K to 41.7K | 24% |
| 19-Mar-08 4:46 PM View: | Stanewick Gerald T Director | Adhera Therapeutics, Inc. (ATRX) | 19-Mar-08 | Market Purchase | 5,000 | $2.40 | $11,991.00 | 3% 160.41K to 165.41K | (100%) |
| 19-Feb-08 5:29 PM View: | York Bruce R Interim CFO, Secretary | Adhera Therapeutics, Inc. (ATRX) | 12-Feb-08 | Grant | 14,400 | -- | -- | (29%) 49.63K to 35.23K | |
| 19-Feb-08 5:35 PM View: | Duffy Timothy M Chief Business Officer | Adhera Therapeutics, Inc. (ATRX) | 12-Feb-08 | Grant | 14,400 | -- | -- | (20%) 71.0K to 56.59K | |
| 20-Dec-07 4:11 PM View: | Brandt Gordon President | Adhera Therapeutics, Inc. (ATRX) | 19-Dec-07 | Grant | 18,000 | -- | -- | 80% 22.5K to 40.5K |
